XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF PRESENTATION (Details)
$ in Millions
Sep. 29, 2023
USD ($)
Discontinued Operations, Disposed of by Sale | BioPharma Solutions  
Disclosure Basis Of Presentation Details [Line Items]  
Pre-tax cash proceeds $ 3,960